References
Hu Z, Li X, Yuan R, Ring BZ, Su L (2010) Three common TP53 polymorphisms in susceptibility to breast cancer, evidence from meta-analysis. Breast Cancer Res Treat 120:705–714
Weston A, Pan CF, Ksieski HB, Wallenstein S, Berkowitz GS, Tartter PI, Bleiweiss IJ, Brower ST, Senie RT, Wolff MS (1997) p53 haplotype determination in breast cancer. Cancer Epidemiol Biomarkers Prev 6:105–112
Zhuo W, Zhang Y, Xiang Z, Cai L, Chen Z (2009) Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controls. J Exp Clin Cancer Res 28:115
Conflict of interest
None of the authors has any potential financial conflict of interest related to this manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Pei-Hua Lu, Min-Bin Chen and Mu-Xin Wei contributed equally to this work and should be considered as co-first authors.
Rights and permissions
About this article
Cite this article
Lu, PH., Chen, MB., Wei, MX. et al. A small number of subjects do not always indicate that they are minor variants data for inclusion in a pooled analysis. Breast Cancer Res Treat 126, 249–252 (2011). https://doi.org/10.1007/s10549-010-1234-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-010-1234-z